Text :: Skip Nav ::
NB: not all articles will remain available on the internet.
House Energy and Commerce Committee Launches Investigation Into Alleged Ethics Violations by Several NIH Officials. Kaiser Daily Health Policy Report. 2003-06-27.
NIH Officials Investigated for Possible Ethics Breach. Rick Weiss. The Washington Post. 2003-06-27.
URL: http://www. washingtonpost.com/wp-dyn/articles/A37557-2003Jun26.html
Former Cancer Institute Official is a Focus of Ethics Investigation. Aaron Zitner. The Los Angeles Times. 2003-06-27.
Studies of Dietary Supplements Come Under Growing Scrutiny. Ford Fessenden. The New York Times. 2003-06-23.
URL: http:// www.nytimes.com/2003/06/23/national/23DIET.html?pagewanted=print&position=
Related: Greenwich Diet Doctor Accused of Fraud – Clinical Studies Alleged to Have Been Falsified. NBC News / New Haven/Hartford CT Affiliate. 2003-06-09.
URL: http://www.nbc30.com/health/2257070/detail. html
San Diego judge rules NJ firm's ads, claims were misleading. Associated Press. 2003-05-30.
URL: http:// www.signonsandiego.com/news/business/20030530-1811-ca-cytodynelawsuit.html
FDA Acts to Reduce Potential Risks of Dietary Supplements Containing Ephedra. FDA Fact Sheet. 2003-02-28.
URL: http://www.fda.gov/bbs/topics/ NEWS/ephedra/factsheet.html
Energy and Commerce Leaders Initiate Examination of Ephedra. News Release. House Committee on Energy and Commerce. 2003-02-28.
URL: http://energycommerce.house.gov/ 108/News/02282003_807.htm
Bechler's diet pills draw scrutiny. Amy Shipley. The Washington Post. 2003-03-19.
New Stem Cell Surgery on Hold. Mike Martindale. The Detroit News. 2003-06-13.
URL: http://www.detnews.com/2003/ health/0306/13/d01-192073.htm
Ill-fated clinical trial never had federal OK Boy, 4, died at CHEO but hospital says it wasn't responsible for getting approvals. Mohammed Adam. The Ottawa Citizen. 2003-06-13.
URL: http://www. canada.com/search/story.aspx?id=8d9fa822-e640-443c-bb0d-d12a1f08f69c
Related: Deadly Clinical trial wasn't approved by Health Canada. CBC Ottawa. 2003-06-12.
Drug error kills child with cancer. CBC News. 2002-10-08.
Health Canada 2002 Chronology / Chimeric Antibody Trial. (ATIP request by The Canadian Broadcasting Company.) Available from http://web.archive.org/web/20040612135616/http://www.ottawa.cbc.ca/ottawanews/newsdocs/chronology.pdf
Talking notes prepared for Health Minister Ann Mclellan. (ATIP request by The Canadian Broadcasting Company.) Available from http://www.ottawa.cbc.ca/ ottawanews/newsdocs/talkingnotes.pdf
Masiello SA. FDA Warning Letter to Jacqueline M. Halton M.D. 2003-04-04. Available from http://www.fda.gov/foi/warning_letters/ g3946d.pdf
Phase III Randomized Study of Adjuvant Isotretinoin With or Without Monoclonal Antibody Ch14.18, Interleukin-2, and Sargramostim (GM-CSF) in Patients With High-Risk Neuroblastoma Who Have Completed Myeloablative Therapy and Autologous Stem Cell Transplantation — Temporarily Closed. National Cancer Institute. 2003-04-30. Available from http://www.nci.nih.gov/clinicaltrials/view_clinicaltrials. aspx?version=healthprofessional&cdrid=69018&protocolsearchid=432979
Masiello SA. FDA Warning Letter to Alice Yu M.D., Ph.D. 2002-04-17. Available from http://www.fda.gov/foi/warning_letters/ g3181d.pdf
Masiello SA. FDA Warning Letter to Titan Pharmaceuticals. 2002-04-15. Available from http://www.fda.gov/foi/warning_letters/ g3180d.pdf
Guilty plea in medical fraud — 12 patients die Bay Area branch of Guidant fined $92 million over malfunctions. Stacy Finz. The San Fransciso Chronicle. 2003-06-13.
URL: http://www. sfgate.com/cgi-bin/article.cgi?file=/c/a/2003/06/13/MN200083.DTL
Health Canada is advising Canadians not to use Empowerplus. Health Canada — Warnings/Advisories. 2003-06-06.
URL: http://www.hc-sc.gc.ca/ english/protection/warnings/2003/2003_41.htm
Related: Questions and Answers — Health Canada's Actions Against Empowerplus.
URL: http://www.hc-sc.gc .ca/english/protection/warnings/2003/empowerplus.htm
Concerns Regarding NutritionalCureand Psychiatric Research. CIRCARE InfoMail. 2002-06-27.
Borror KC. Office for Human Research Protections Determination Letter Issued to the University of Utah. 2002-08-19. Available from http://www.hhs.gov/ohrp/detrm_letrs/YR02/aug02e.pdf
Assessing the Risks, Benefits of Clinical Trials. Beth Baker. AARP Bulletin Online. June, 2003.
URL: http://www.aarp.org /bulletin/departments/2003/health/0605_health_1.html
Related: 8 Questions to Ask Before You Sign Up for a Clinical Trial. AARP. Available from http://www.aarp.org/bulletin/departments/2003/health/0605_sidebar_2.html
Ernst E, Canter PH. Investigator bias and false positive findings in medical research. Trends in Pharmacological Sciences. 2003;24:219-221. Available from http://reviews.bmn.com/journals/atoz/latest?uid=TIPS.bmn06580_01656147_v0024i05_03000750
GMC reprimands doctor for research fraud. Owen Dyer. British Medical Journal. 2003;326:730.
URL: http://bmj.com/cgi/content/full/326 /7392/730/
Suffer the little children in the search for cures. Dan Vergano. USA Today. 2003-05-29.
URL: http://www.usatoday .com/tech/news/techpolicy/2003-05-28-kids-usat_x.htm
FDA Warning Letter Hints at Crackdown on Unregulated Research, IND Enforcement. M. Alexander Otto. Medical Research Law & Policy Report / BNA. 2003-05-07. Available from http://www.circare.org/bna05072003.pdf
Related: JHU Researcher found to have violated rules. FDA proposes restrictions; study resulted in death. Julie Bell. The Baltimore Sun. 2003-04-18.
URL: http://www.sunspot.net/news/ local/bal-md.hopkins18apr18.story
FDA Warning Letter to Alkis Togias M.D. / Johns Hopkins Asthma and Allergy Center. 2003-03-31. Available from http://www.fda.gov/cder/warn/2003/02- hfd-45-0303.pdf
Form FDA 483 Notice of Inspectional Observations, Issued to Alkis Togias M.D. / Johns Hopkins Asthma and Allergy Center. 2001-06-28. Available from http://www.fda.gov/ora/frequent/ 483s/JohnHopkins483.html
Restart of drug-testing study rejected. Andy Dworkin. The Oregonian. 2003-04-30.
Related: Borror KC. OHRP Determination Letter to Oregon Health and Science University. 2003-04-17. Available from http://www.hhs.gov/ohrp/detrm_letrs/YR03/apr03c.pdf
Borror KC. OHRP Determination Letter to Oregon Health and Science University. 2002-12-10. Available from http://www.hhs.gov/ohrp/detrm_letrs/YR02/dec02f.pdf
Borror KC. OHRP Determination Letter to Oregon Health and Science University. 2002-10-24. Available from http://www.hhs.gov/ohrp/detrm_letrs/YR02/oct02d.pdf
Borror KC. OHRP Determination Letter to Oregon Health and Science University. 2002-10-04. Available from http://www.hhs.gov/ohrp/detrm_letrs/YR02/oct02a.pdf
Board rebukes AIDS evaluator — Doctor had helped Heimlich associate. Robert Anglen. The Cincinnati Enquirer. 2003-04-18.
URL: http://www.enquirer.com/ editions/2003/04/18/loc_heimlich18.html
Related: Heimlich maneuvers in AIDS Therapy. Rueters. 2003-04-14.
URL: http:// www.cnn.com/2003/HEALTH/conditions/04/14/health.aids.malaria.reut/index.html
Researcher Violated Rules, says UCLA. Rebecca Trounson and Charles Ornstein. The Los Angeles Times. 2003-04-16.
URL: http://www.latimes.com/la-me- malaria16apr16,0,650344.story
Therapy's value challenged Medical community split on controversial AIDS treatment. Jeyling Chou. The Daily Bruin. 2003-02-23.
Scientists linked to Heimlich investigated – Experiment infects AIDS patients in China with malaria. Robert Anglen. The Cincinnati Enquirer. 2003-02-16.
URL: http://enquirer.com/editions/ 2003/02/16/loc_heimlich16.html
Researchers' possible link to malariotherapy scrutinized. Edward Chiao and Jeyling Chou. The Daily Bruin Online. 2002-11-22.
A Matter of Trust. CBC News. 2003-04-01.
URL: http://www.cbc.ca/consumers/indepth/ medical/index.html
Disclosures for cancer research — Scientists must reveal financial ties. Bernadette Tansey. The San Francisco Chronicle. 2003-04-30.
URL: http://www.sfgate. com/cgi-bin/article.cgi?f=/c/a/2003/04/30/BU176961.DTL
American Society of Clinical Oncology Policy Statement: Oversight of Clinical Research. Journal of Clinical Oncology. 2003;21(12). Available from http://www.jco.org/cgi/reprint/JCO. 2003.04.026v1.pdf
American Society of Clinical Oncology: Background for Update of Conflict of Interest Policy. Journal of Clinical Oncology. 2003;21(12). Available from http://www.jco.org/cgi/reprint/JCO. 2003.04.025v1.pdf
American Society of Clinical Oncology: Revised Conflict of Interest Policy. Journal of Clinical Oncology. 2003;21(12). Available from http://www.jco.org/cgi/reprint/JCO. 2003.04.524v1.pdf
American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility. Journal of Clinical Oncology. 2003;21(12). Available from http://www.jco.org/cgi/reprint/JCO. 2003.03.189v1.pdf
Last Updated: 2006-07-17
If you find the information on this page helpful please support CIRCARE with a tax-deductible contribution today. Because CIRCARE doesn't accept funds from pharmaceutical or medical device manufacturers, we depend on contributions from individuals like you to help us advocate for meaningful protection of human subjects in research. Donating on-line with PayPal is quick and easy. Find out more on our Support page.
All material on this site © CIRCARE Incorporated (2002- ) unless otherwise noted. Single copies can be downloaded for personal education. Adobe® Reader :: ::